Citation Impact
Citing Papers
IMPOTENCE AND ITS NON‐SURGICAL MANAGEMENT
1997
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Cochrane Database of Systematic Reviews
2003 Standout
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
2009
Engineering precision nanoparticles for drug delivery
2020 Standout
Penile Response to Intracavernosal Vasoactive Intestinal Polypeptide Alone and in Combination with Other Vasoactive Agents
1989
Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3,885 Patients
1989 Standout
Cancer Incidence in BRCA1 Mutation Carriers
2002
Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy
2012 Standout
Brain Hydroxyl Radical Generation in Acute Experimental Head Injury
1993
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Spinal-cord injury
2002 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management
2010
Erectile Dysfunction
2000 Standout
The emerging role of lncRNAs in cancer
2015 Standout
Intracavernous prostaglandin E1 in erectile dysfunction
1994
A3-adenosine receptors: Design of selective ligands and therapeutic prospects
1995
Prostaglandin E Receptor EP3 Subtype Induces Neurite Retraction via Small GTPase Rho
1996
Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy
1998
Multifunctional Gold Nanoshells on Silica Nanorattles: A Platform for the Combination of Photothermal Therapy and Chemotherapy with Low Systemic Toxicity
2010
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Therapeutic Uses of Botulinum Toxin
1991
An ionizable lipid toolbox for RNA delivery
2021 StandoutNobel
Nanocarriers’ entry into the cell: relevance to drug delivery
2009
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer
2016
Challenges for providing effective hemostasis in surgery and trauma
2004
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
1996 StandoutNobel
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
1998
Oral Sildenafil in the Treatment of Erectile Dysfunction
1998 Standout
Bladder cancer
2016 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
The hallmarks of cancer
2012 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission
1992 StandoutNobel
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors
2018
Treatment of Infections Associated with Surgical Implants
2004 Standout
Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate
1996
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Initial urologic management of myelomeningocele
2004
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Predictors of Success and Risk Factors for Attrition in the Use of Intracavernous Injection
1997
DEEP SOFT-TISSUE INFECTIONS IN DIABETIC PATIENTS
1995
Nitric Oxide: A Physiologic Mediator of Penile Erection
1992 StandoutScience
Can Stage A1 Tumor Extent be Predicted by Transurethral Resection Tumor Volume, Per Cent or Grade? A Study of 64 Stage A1 Radical Prostatectomies with Comparison to Prostates Removed for Stages A2 and B Disease
1991
Management of the Bladder Outlet in Patients Requiring Enterocystoplasty
1992
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
1996
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
HERPES SIMPLEX VIRUS BASED GENE THERAPY ENHANCES THE EFFICACY OF MITOMYCIN C FOR THE TREATMENT OF HUMAN BLADDER TRANSITIONAL CELL CARCINOMA
2005
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Interactions of Flavonoids and Other Phytochemicals with Adenosine Receptors
1996
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Rho GTPases and the Actin Cytoskeleton
1998 StandoutScience
Impotence: A patient's goal-directed approach to treatment
1990
Multifunctional Gold Nanoshells on Silica Nanorattles: A Platform for the Combination of Photothermal Therapy and Chemotherapy with Low Systemic Toxicity
2010
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Inflatable Penile Implant Infection: Predisposing Factors and Treatment Suggestions
1995
Prostaglandin E1 Versus Phentolamine/Papaverine for the Treatment of Erectile Impotence: A Double-Blind Comparison
1989
Mechanisms of Diabetic Complications
2013 Standout
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Sexual Function and Dysfunction after Spinal Cord Injury
1992
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Erectile Responses to Intracavernous Papaverine and Phentolamine: Comparison of Single and Combined Delivery
1988
Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing
2017
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Using SV119‐Gold Nanocage Conjugates to Eradicate Cancer Stem Cells Through a Combination of Photothermal and Chemo Therapies
2014
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Physiology of Erection and Pharmacological Management of Impotence
1987
Current and Future Pharmacological Treatment for Overactive Bladder
2002
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Intracavernous Injection of Prostaglandin E1 in Impotent Men
1988
Nitric Oxide is a Potent Relaxant of Human and Rabbit Corpus Cavernosum
1992 StandoutNobel
Works of A. Sidi being referenced
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
2000
Cardiovascular effects of a non-xanthine-selective antagonist of the A1 adenosine receptor in the anaesthetised pig: pharmacological and therapeutic implications
1994
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer
2004
Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder
2004
Intracavernous Drug-Induced Erections in the Management of Male Erectile Dysfunction: Experience with 100 Patients
1986
Penile Prosthesis Surgery in the Treatment of Impotence in the Immunosuppressed Man
1987
Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients
1988
Clinical experience with vasoactive intracavernous pharmacotherapy for treatment of impotence
1987
Head Injury Induces Increased Prostaglandin Synthesis in Rat Brain
1987
Vasoactive Intracavernous Pharmacotherapy
1988
Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin
2008
Long-Term Followup Results After Expectant Management of Stage A1 Prostatic Cancer
1991
Patient Acceptance of and Satisfaction with an External Negative Pressure Device for Impotence
1990
Factor XI Deficiency: Detection and Management During Urological Surgery
1978
Compatibility of Enterocystoplasty and the Artificial Urinary Sphincter
1989
Vasoactive Intracavernous Pharmacotherapy for the Treatment of Erectile Impotence in Men with Spinal Cord Injury
1987
Patient Acceptance of and Satisfaction with Vasoactive Intracavernous Pharmacotherapy for Impotence
1988
The Value of Urodynamic Testing in the Management of Neonates with Myelodysplasia: A Prospective Study
1986
Prophylactic antimicrobial treatment in transurethral prostatectomy How long should it be instituted?
1983
Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study.
1990
Preoperative Prediction of Continence After Enterocystoplasty or Undiversion in Children with Neurogenic Bladder
1985